Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Orexo

Explore full profile

Pharmaceutical company developing improved treatments using proprietary drug delivery technology

Uppsala kommun, SwedenFounded 1995Biotech & Life Sciences
Valuation $20M Market cap · 2026
Revenue $2.3M Latest reported FY

About Orexo

Orexo is a Swedish pharmaceutical company with a track record spanning three decades in the development of enhanced pharmaceuticals. The company leverages its proprietary drug delivery technologies to address significant medical needs.

In the United States, Orexo is focused on providing treatment solutions for individuals with opioid use disorder. For other therapeutic areas, the company collaborates with international partners to develop and commercialize its products. The company's total net sales reached SEK 590 million in 2024, with a workforce of 110 employees. Orexo's shares are traded on the main list of Nasdaq Stockholm and are also available as American Depositary Receipts (ADRs) on the OTCQX market in the US under the ticker ORXOY.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1995
Headquarters
Uppsala kommun, Sweden
Listing
IPO 2005
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • HealthCap
  • Auriga Partners
  • Sofinnova Investments
  • Apex Venture Partners
  • Crédit Lyonnais Private Equity

Series B and later5 investors entered at this stage

  • Crédit Lyonnais Private Equity
  • Auriga Partners
  • HealthCap
  • Apex Venture Partners
  • Sofinnova Investments

Talent

Book a demo to see the people
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇸🇪 Sweden87.3%
🇺🇸 United States10.9%
🇩🇰 Denmark1.8%
3 countries shown
Web traffic by country
5.2K monthly visits
across markets
🇺🇸 United States63.5%
🇮🇳 India36.5%
Top 2 markets shown

Patents

Estimated portfolio value
$21M

17 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Orexo on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Orexo on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles